DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Baselga J, Tripathy D, Mendelsohn J. et al.
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer
Semin Oncol 1999; 26(suppl 12): 78-83
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.